NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer.

@article{Hall2015NICEGO,
  title={NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer.},
  author={Caroline J Hall and Nicola Hay and Elisabeth L. George and Amanda Ingham Adler},
  journal={The Lancet. Oncology},
  year={2015},
  volume={16 9},
  pages={1019-1020}
}